Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Safety and efficacy of ex vivo expanded CD34+ stem cells in murine and primate models

Fig. 2

Effects of HEM on the ex vivo expansion of human HSCs from different sources. Human CD34+ cells purified from fresh UCB, cryopreserved CB, and mPB were cultured with HEM to day 4 or day 9. Total cell (a) and CD34+ cell (b) expansion was calculated as fold increase (after/before expansion) in cell counts on each day (days 0, 4, and 9). Data are shown as mean ± SD, n = 10. c Types of CFU colonies formed from the hematopoietic stem/progenitor cells before/after expansion. Equal numbers of unexpanded human CD34+ cells and 9-day HEM-expanded CD34+ cells (1 × 104 per dish) were assayed as described in Methods. Data are shown as mean ± SD, n = 4. Pairwise comparisons (unexpanded vs expanded) were performed for each type of colony using Student’s t test (p > 0.05 for all pairs). df Representative flow analysis for multi-immunophenotyping of the expanded cells on day 0, day 4, and day9. Gates of CD34+ CD38, CD90+, CD45RA, and CD49f+ cell populations were set based on the fluorescence minus one (FMO) of each cell surface marker antibody. CD38, CD90+, CD45RA, and CD49f+ were analyzed in CD34+ cell population

Back to article page